Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017.

Vos LM, Teirlinck AC, Lozano JE, Vega T, Donker GA, Hoepelman AI, Bont LJ, Oosterheert JJ, Meijer A.

Euro Surveill. 2019 May;24(20). doi: 10.2807/1560-7917.ES.2019.24.20.1800469.

2.

Pitfalls of molecular diagnostic testing for Coxiella burnetii DNA on throat swabs.

Buijs SB, Hermans MHA, Agni N, de Vries MC, Hoepelman AIM, Oosterheert JJ, Wever PC.

J Microbiol Methods. 2019 Jul;162:16-20. doi: 10.1016/j.mimet.2019.05.006. Epub 2019 May 14.

PMID:
31100316
3.

More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients.

Vos LM, Weehuizen JM, Hoepelman AIM, Kaasjager KHAH, Riezebos-Brilman A, Oosterheert JJ.

J Clin Virol. 2019 Jul;116:11-17. doi: 10.1016/j.jcv.2019.04.003. Epub 2019 Apr 7.

PMID:
30999234
4.

Response to: Q fever mortality in the Netherlands, why so high?

van Roeden SE, Wever PC, Oosterheert JJ.

Clin Microbiol Infect. 2019 Mar 23. pii: S1198-743X(19)30106-5. doi: 10.1016/j.cmi.2019.03.004. [Epub ahead of print] No abstract available.

PMID:
30910718
5.

High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands.

Vos LM, Oosterheert JJ, Kuil SD, Viveen M, Bont LJ, Hoepelman AIM, Coenjaerts FEJ.

J Clin Virol. 2019 Mar;112:20-26. doi: 10.1016/j.jcv.2019.01.007. Epub 2019 Jan 23.

PMID:
30708281
6.

Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).

van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, Fernández D, Kreisberg R, Collins LV, de Waal W, de Winter-de Groot KM, Wolfs TFW, Meijers P, Luijk B, Oosterheert JJ, Heijligenberg R, Sankatsing SUC, Bossink AWJ, Stubbs A, Stein M, Reisfeld S, Klein A, Rachmilevitch R, Ashkar J, Braverman I, Kartun V, Chistyakov I, Bamberger E, Srugo I, Odeh M, Schiff E, Dotan Y, Boico O, Navon R, Friedman T, Etshtein L, Paz M, Gottlieb TM, Pri-Or E, Kronenfeld G, Simon E, Oved K, Eden E, Bont LJ.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514. doi: 10.1007/s10096-018-03454-2. Epub 2019 Feb 1.

7.

Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review of diagnostic accuracy and clinical impact studies.

Vos LM, Bruning AHL, Reitsma JB, Schuurman R, Riezebos-Brilman A, Hoepelman AIM, Oosterheert JJ.

Clin Infect Dis. 2019 Jan 28. doi: 10.1093/cid/ciz056. [Epub ahead of print]

PMID:
30689772
8.

Coxiella burnetii in non-Hodgkin lymphoma tissue samples: Innocent until proven otherwise?

van Roeden SE, Hermans MHA, Nooijen PTGA, Herbers A, Bleeker-Rovers CP, Hoepelman AIM, Oosterheert JJ, Wever PC.

Immunobiology. 2019 Mar;224(2):254-261. doi: 10.1016/j.imbio.2018.11.012. Epub 2018 Dec 5.

PMID:
30638649
9.

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.

Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.

BMC Infect Dis. 2019 Jan 7;19(1):17. doi: 10.1186/s12879-018-3630-7.

10.

Chronic Q fever-related complications and mortality: data from a nationwide cohort.

van Roeden SE, Wever PC, Kampschreur LM, Gruteke P, van der Hoek W, Hoepelman AIM, Bleeker-Rovers CP, Oosterheert JJ.

Clin Microbiol Infect. 2018 Dec 10. pii: S1198-743X(18)30766-3. doi: 10.1016/j.cmi.2018.11.023. [Epub ahead of print]

PMID:
30543852
11.

Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.

Schweitzer VA, van Werkhoven CH, van Heijl I, Smits RF, Boel CHE, Bonten MJM, Postma DF, Oosterheert JJ.

Neth J Med. 2018 Nov;76(9):389-396.

12.

Syndromic sample-to-result PCR testing for respiratory infections in adult patients.

Vos LM, Riezebos-Brilman A, Schuurman R, Hoepelman AIM, Oosterheert JJ.

Neth J Med. 2018 Aug;76(6):286-293.

13.

Chronic Q fever: patient and treatment-related factors influencing long-term quality of life.

van Roeden SE, Reukers DFM, van Jaarsveld CHM, Kampschreur LM, Hoepelman IM, Wever PC, Bleeker-Rovers CP, Oosterheert JJ.

QJM. 2018 Nov 1;111(11):791-797. doi: 10.1093/qjmed/hcy171.

PMID:
30102400
14.

Primary and secondary arterial fistulas during chronic Q fever.

Karhof S, van Roeden SE, Oosterheert JJ, Bleeker-Rovers CP, Renders NHM, de Borst GJ, Kampschreur LM, Hoepelman AIM, Koning OHJ, Wever PC.

J Vasc Surg. 2018 Dec;68(6):1906-1913.e1. doi: 10.1016/j.jvs.2018.01.044.

PMID:
29685511
15.

Exposure to Coxiella burnetii and risk of non-Hodgkin lymphoma: a retrospective population-based analysis in the Netherlands.

van Roeden SE, van Houwelingen F, Donkers CMJ, Hogewoning SJ, de Lange MMA, van der Hoek W, Kampschreur LM, Bonten MJM, Hoepelman AIM, Bleeker-Rovers CP, Wever PC, Oosterheert JJ.

Lancet Haematol. 2018 May;5(5):e211-e219. doi: 10.1016/S2352-3026(18)30038-3. Epub 2018 Apr 9.

PMID:
29650493
16.

Seroprevalence of Coxiella burnetii antibodies and chronic Q fever among post-mortal and living donors of tissues and cells from 2010 to 2015 in the Netherlands.

van Roeden SE, Holsboer EW, Oosterheert JJ, van Kats JP, van Beckhoven J, Hogema BM, van Wijk MJ.

Euro Surveill. 2018 Mar;23(9). doi: 10.2807/1560-7917.ES.2018.23.9.17-00384.

17.

The effect of measuring serum doxycycline concentrations on clinical outcomes during treatment of chronic Q fever.

van Roeden SE, Bleeker-Rovers CP, Kampschreur LM, de Regt MJA, Vermeulen Windsant A, Hoepelman AIM, Wever PC, Oosterheert JJ.

J Antimicrob Chemother. 2018 Apr 1;73(4):1068-1076. doi: 10.1093/jac/dkx487.

PMID:
29325142
18.

Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?

Postma DF, van Werkhoven CH, Troeman DPR, Sankatsing SUC, Oosterheert JJ, Bonten MJM.

Eur Respir J. 2017 Oct 19;50(4). pii: 1700307. doi: 10.1183/13993003.00307-2017. Print 2017 Oct. No abstract available.

19.

Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens.

van Roeden SE, Bleeker-Rovers CP, de Regt MJA, Kampschreur LM, Hoepelman AIM, Wever PC, Oosterheert JJ.

Clin Infect Dis. 2018 Feb 10;66(5):719-726. doi: 10.1093/cid/cix886.

PMID:
29040457
20.

Rapid Tests for Common Respiratory Viruses.

Vos LM, Riezebos-Brilman A, Hoepelman AIM, Oosterheert JJ.

Clin Infect Dis. 2017 Nov 13;65(11):1958-1959. doi: 10.1093/cid/cix700. No abstract available.

PMID:
29020183
21.

Case report: Coxiella burnetii vascular infection and lymphoma in the Netherlands.

van Roeden SE, Melenotte C, Hermans MHA, Sinnige HAM, Nooijen PTGA, Audoly G, Hoepelman AIM, Oosterheert JJ, Raoult D, Wever PC.

Infection. 2018 Feb;46(1):131-134. doi: 10.1007/s15010-017-1061-9. Epub 2017 Aug 24.

22.

Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.

van Werkhoven CH, van de Garde EMW, Oosterheert JJ, Postma DF, Bonten MJM.

Respir Med. 2017 Aug;129:145-151. doi: 10.1016/j.rmed.2017.06.012. Epub 2017 Jun 20.

PMID:
28732822
23.

Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to compare strategies to optimize antibiotic use.

Schweitzer VA, van Smeden M, Postma DF, Oosterheert JJ, Bonten MJM, van Werkhoven CH.

Clin Microbiol Infect. 2017 Dec;23(12):980-985. doi: 10.1016/j.cmi.2017.05.003. Epub 2017 May 10.

24.

Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients.

Simonetti AF, van Werkhoven CH, Schweitzer VA, Viasus D, Carratalà J, Postma DF, Oosterheert JJ, Bonten MJM.

Clin Microbiol Infect. 2017 Oct;23(10):774.e1-774.e7. doi: 10.1016/j.cmi.2017.03.010. Epub 2017 Mar 20.

25.

Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines.

Postma DF, van Werkhoven CH, Oosterheert JJ.

Curr Opin Pulm Med. 2017 May;23(3):204-210. doi: 10.1097/MCP.0000000000000371. Review.

PMID:
28198726
26.

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.

van Werkhoven CH, Postma DF, Mangen MJ, Oosterheert JJ, Bonten MJ; CAP-START study group.

BMC Infect Dis. 2017 Jan 10;17(1):52. doi: 10.1186/s12879-016-2179-6.

27.

Management of Community-Acquired Pneumonia.

van Werkhoven CH, Oosterheert JJ, Bonten MJ.

JAMA. 2016 Jul 12;316(2):221-2. doi: 10.1001/jama.2016.5022. No abstract available.

PMID:
27404194
28.

The High Impact of Penicillin Allergy Registration in Hospitalized Patients.

van Dijk SM, Gardarsdottir H, Wassenberg MW, Oosterheert JJ, de Groot MC, Rockmann H.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):926-31. doi: 10.1016/j.jaip.2016.03.009. Epub 2016 Apr 28.

29.

No Value for Routine Serologic Screening for Borrelia burgdorferi in Patients With Uveitis in the Netherlands.

Kazi H, de Groot-Mijnes JDF, Ten Dam-van Loon NH, Ossewaarde-van Norel J, Oosterheert JJ, de Boer JH.

Am J Ophthalmol. 2016 Jun;166:189-193. doi: 10.1016/j.ajo.2016.04.002. Epub 2016 Apr 11.

PMID:
27080573
30.

Treatment restrictions and empirical antibiotic treatment of community-acquired pneumonia in elderly patients.

Mulder T, van Werkhoven CH, Huijts SM, Bonten MJ, Postma DF, Oosterheert JJ.

Neth J Med. 2016 Jan;74(1):56. No abstract available.

31.

Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia.

van Werkhoven CH, Huijts SM, Postma DF, Oosterheert JJ, Bonten MJ.

PLoS One. 2015 Nov 24;10(11):e0143817. doi: 10.1371/journal.pone.0143817. eCollection 2015.

32.

Chronic Q fever diagnosis— consensus guideline versus expert opinion

Kampschreur LM, Wegdam-Blans MC, Wever PC, Renders NH, Delsing CE, Sprong T, van Kasteren ME, Bijlmer H, Notermans D, Oosterheert JJ, Stals FS, Nabuurs-Franssen MH, Bleeker-Rovers CP; Dutch Q Fever Consensus Group.

Emerg Infect Dis. 2015 Jul;21(7):1183-8.

33.

Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.

van Werkhoven CH, van der Tempel J, Jajou R, Thijsen SF, Diepersloot RJ, Bonten MJ, Postma DF, Oosterheert JJ.

Clin Microbiol Infect. 2015 Aug;21(8):786.e1-8. doi: 10.1016/j.cmi.2015.04.005. Epub 2015 Apr 16.

34.

Antibiotic treatment strategies for community-acquired pneumonia in adults.

Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, Boersma WG, Compaijen CJ, van der Wall E, Prins JM, Oosterheert JJ, Bonten MJ; CAP-START Study Group.

N Engl J Med. 2015 Apr 2;372(14):1312-23. doi: 10.1056/NEJMoa1406330.

35.

[Middle-East respiratory syndrome].

Oosterheert JJ, Hoepelman AI.

Ned Tijdschr Geneeskd. 2014;158:A8119. Dutch.

PMID:
25248740
36.

Molecular and Serological Intraocular Fluid Analysis of Coxiella burnetii-seropositive Patients with Concurrent Idiopathic Uveitis.

Hermans LE, Oosterheert JJ, Kampschreur LM, Ossewaarde-van Norel J, Dekkers J, Rothova A, de Groot-Mijnes JD.

Ocul Immunol Inflamm. 2016;24(1):77-80. doi: 10.3109/09273948.2014.925123. Epub 2014 Jun 19.

PMID:
24945498
37.

A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study.

Engel MF, Bruns AH, Hulscher ME, Gaillard CA, Sankatsing SU, Teding van Berkhout F, Emmelot-Vonk MH, Kuck EM, Steeghs MH, den Breeijen JH, Stellato RK, Hoepelman AI, Oosterheert JJ.

Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1897-908. doi: 10.1007/s10096-014-2158-z. Epub 2014 May 26.

PMID:
24859925
38.
39.

Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy.

Schoffelen T, Kampschreur LM, van Roeden SE, Wever PC, den Broeder AA, Nabuurs-Franssen MH, Sprong T, Joosten LA, van Riel PL, Oosterheert JJ, van Deuren M, Creemers MC.

Ann Rheum Dis. 2014 Jul;73(7):1436-8. doi: 10.1136/annrheumdis-2014-205455. Epub 2014 May 2. No abstract available.

PMID:
24794150
40.

Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, Hoepelman AI, van Kasteren ME, Buijs J, Renders NH, Nabuurs-Franssen MH, Oosterheert JJ, Wever PC.

J Clin Microbiol. 2014 May;52(5):1637-43. doi: 10.1128/JCM.03221-13. Epub 2014 Mar 5.

41.

Predicting community-acquired pneumonia etiology.

Postma DF, van Werkhoven CH, Oosterheert JJ, Bonten MJM.

Chest. 2013 Dec;144(6):1975-1976. doi: 10.1378/chest.13-1756. No abstract available.

PMID:
24297141
42.

Antibiotic prophylaxis for high-risk patients with acute Q Fever: no definitive answers yet.

Kampschreur LM, Oosterheert JJ, Wever PC, Bleeker-Rovers CP.

Clin Infect Dis. 2014 Feb;58(3):446-7. doi: 10.1093/cid/cit718. Epub 2013 Nov 5. No abstract available.

PMID:
24192385
43.

Observed mortality reduction in patients hospitalized with community-acquired pneumonia may well be confounded by disease severity.

van Werkhoven CH, Postma DF, Oosterheert JJ, Bonten MJ.

Am J Med. 2013 Nov;126(11):e23. doi: 10.1016/j.amjmed.2013.02.028. No abstract available.

PMID:
24157296
44.

Long-term survival in community-acquired pneumonia caused by other bacteria than pneumococci is impaired more than in pneumococcal pneumonia: effect of underlying disease?

Bruns AH, Oosterheert JJ, Hoepelman AI.

Clin Infect Dis. 2013 Nov;57(9):1370-1. doi: 10.1093/cid/cit507. Epub 2013 Aug 8. No abstract available.

PMID:
23929891
45.

The role of vitamin D supplementation in the risk of developing pneumonia: three independent case-control studies.

Remmelts HH, Spoorenberg SM, Oosterheert JJ, Bos WJ, de Groot MC, van de Garde EM.

Thorax. 2013 Nov;68(11):990-6. doi: 10.1136/thoraxjnl-2013-203623. Epub 2013 Jul 26.

PMID:
23892991
46.

Two cases of Plasmodium falciparum malaria in the Netherlands without recent travel to a malaria-endemic country.

Arends JE, Oosterheert JJ, Kraaij-Dirkzwager MM, Kaan JA, Fanoy EB, Haas PJ, Scholte EJ, Kortbeek LM, Sankatsing SU.

Am J Trop Med Hyg. 2013 Sep;89(3):527-30. doi: 10.4269/ajtmh.13-0213. Epub 2013 Jul 15.

47.

Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation.

Engel MF, van Manen L, Hoepelman AI, Thijsen S, Oosterheert JJ.

J Clin Pathol. 2013 Sep;66(9):797-802. doi: 10.1136/jclinpath-2012-201209. Epub 2013 Jun 17.

PMID:
23775436
48.

Diagnosis and treatment of tuberculous uveitis in a low endemic setting.

Vos AG, Wassenberg MW, de Hoog J, Oosterheert JJ.

Int J Infect Dis. 2013 Nov;17(11):e993-9. doi: 10.1016/j.ijid.2013.03.019. Epub 2013 May 22.

49.

The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

Troeman DP, Postma DF, van Werkhoven CH, Oosterheert JJ.

J Infect. 2013 Aug;67(2):93-101. doi: 10.1016/j.jinf.2013.04.015. Epub 2013 May 8. Review.

PMID:
23665030
50.

Delayed diagnosis of chronic Q fever and cardiac valve surgery.

Kampschreur LM, Hoornenborg E, Renders NH, Oosterheert JJ, Haverman JF, Elsman P, Wever PC.

Emerg Infect Dis. 2013 May;19(5):768-70. doi: 10.3201/eid1905.120353.

Supplemental Content

Loading ...
Support Center